ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637921 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637921; 2) Community: the network communities that were significantly associated with the response to NSC 637921; 3) Molecule: the relationships between components within communities and NSC 637921; 4) MDR: the compounds that were significantly associated with the NSC 637921.

NSC Compound Enrichment Correlation
NSC 638635 Propyl-1-aminium, 3-[3,5-bis(phenylmethylene)-4-oxo- piperidin-1-yl]-3-oxo-N,N,N-trimethyl-, bromide 0.0385613993886001 -0.40149543
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.0385613993886001 -0.46404454
NSC 639977 Null 0.0385613993886001 -0.33661235
NSC 647395 Null 0.0385613993886001 -0.31512574
NSC 654509 Pirarubicin HCl 0.0385613993886001 -0.023308272
NSC 667874 Null 0.0385613993886001 -0.44643083
NSC 673784 Naphthalen-1(4H)-one, 2-hydroxy-4-[(5-methyl-3-isoxazolyl)imino]- 0.0385613993886001 -0.21058874
NSC 675967 Null 0.0385613993886001 -0.27843445
NSC 677020 Benzoic acid, 2-[1,3,4',5'-tetrahydro-1-oxospiro[2H-inden- 2,3'-[3H]pyrazol]-4'-yl]-4-methyl-, methyl ester 0.0385613993886001 -0.30452796
NSC 682825 Propanimidoyl chloride, N-[[[(4-bromophenyl)amino] carbonyl]oxy]-2-methyl- 0.0385613993886001 -0.30850612
Total:108  Current:96    [First] [Prev] [Next] [Last]